Tevogen Bio Holdings (TVGN) Other Non-Current Liabilities (2022 - 2026)

Tevogen Bio Holdings has reported Other Non-Current Liabilities for 5 years, with the latest figure at $648.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 99.12% year-over-year to $648.0; the trailing twelve-month figure through Mar 2026 stood at $648.0 (down 99.12% YoY), and the FY2025 full-year result was $26479.0, down 69.63% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $648.0, down from $26479.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $14.0 million in Q2 2024, with the low at $648.0 in Q1 2026.
• Historically, Other Non-Current Liabilities has averaged $2.2 million across 5 years, with a median of $73323.0 in 2025.
• Annual changes were most pronounced in 2024 — Other Non-Current Liabilities jumped 23233.33% — and 2026, when it tumbled 99.12%.
• Tevogen Bio Holdings' Other Non-Current Liabilities stood at $120000.0 in 2022, then surged by 91.67% to $230000.0 in 2023, then sank by 62.1% to $87180.0 in 2024, then slumped by 69.63% to $26479.0 in 2025, then slumped by 97.55% to $648.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $648.0 (Q1 2026), $26479.0 (Q4 2025), and $29774.0 (Q3 2025), per Business Quant data.